Sunshine Biopharma Stock Price, News & Analysis
Company Description
Sunshine Biopharma (NASDAQ: SBFMW) is a publicly traded company in the Pharmaceutical Preparations sector.
SBFMW stock has declined 52.1% over the past year. Shares last traded at $0.1390.
On a trailing twelve-month basis, Sunshine Biopharma reported revenue of $34.9M with net income of -$5.1M and diluted earnings per share of $-7.32. The company operates at a net profit margin of -14.7%.
This page provides a comprehensive overview of SBFMW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Sunshine Biopharma (SBFMW) stock last traded at $0.1390. Over the past 12 months, the stock has lost 52.1%.
Latest News
Sunshine Biopharma has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 8 with negative movement. Key topics include earnings, private placement, covid-19, buybacks. View all SBFMW news →
SEC Filings
Sunshine Biopharma has filed 5 recent SEC filings, including 2 Form 8-K, 1 Form 4, 1 Form 10-K, 1 Form DEF 14C. The most recent filing was submitted on April 14, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SBFMW SEC filings →
Financial Highlights
Sunshine Biopharma generated $34.9M in revenue over the trailing twelve months, retaining a 30.6% gross margin, operating income reached -$5.8M (-16.7% operating margin), and net income was -$5.1M, reflecting a -14.7% net profit margin. Diluted earnings per share stood at $-7.32. The company generated -$12.5M in operating cash flow. With a current ratio of 4.11, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Sunshine Biopharma (SBFMW) currently stands at 5.6 thousand shares, down 7.4% from the previous reporting period, representing 0.2% of the float. Over the past 12 months, short interest has decreased by 29.6%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Sunshine Biopharma (SBFMW) currently stands at 2.9 days, up 191% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The ratio has shown significant volatility over the period, ranging from 1.0 to 12.0 days.
SBFMW Company Profile & Sector Positioning
Sunshine Biopharma (SBFMW) operates in the Pharmaceutical Preparations sector and is listed on the NASDAQ.
Investors comparing SBFMW often look at related companies in the same sector, including Biofrontera (BFRIW), Clever Leaves Holdings Inc (CLVRW), Sunshine Biopharma Inc (SBFM), Inmed Pharmaceuticals Inc (INM), and Aytu Biopharma Inc (AYTU). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SBFMW's relative position within its industry.